MOZI-Q (Xerion Dispensary Ltd.)


Welcome to the PulseAid listing for the MOZI-Q drug offered from Xerion Dispensary Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Xerion Dispensary Ltd.
NON-PROPRIETARY NAME: Ledum Palustre Twig, Urtica Urens, Simaba Cedron Seed, Delphinium Staphisagria Seed, Grindelia Hirsutula Flowering Top
SUBSTANCE NAME: LEDUM PALUSTRE TWIG; URTICA URENS; SIMABA CEDRON SEED; DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA FLOWERING TOP
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-10-15
END MARKETING DATE: 0000-00-00


MOZI-Q HUMAN OTC DRUG Details:

Item DescriptionMOZI-Q from Xerion Dispensary Ltd.
LABELER NAME: Xerion Dispensary Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 6; 4; 4; 6([hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1)
START MARKETING DATE: 2012-10-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53590-100_198ef84d-7087-4fd7-bceb-d39f423f48f5
PRODUCT NDC: 53590-100
APPLICATION NUMBER:

Other LEDUM PALUSTRE TWIG; URTICA URENS; SIMABA CEDRON SEED; DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA FLOWERING TOP Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Xerion Dispensary Ltd.MOZI-Q